Punch: Preliminary results from a phase II study of intra-arterial chemotherapy (IAC) combined with tislelizumab and bacillus Calmette-Guerin (BCG) in high-risk non-muscle-invasive bladder cancer (HR NMIBC).
Zongren Wang(Sun Yat-sen University), Junxing Chen(Sun Yat-sen University), Bin Huang(North Sichuan Medical University), Lingwu Chen(Sun Yat-sen University), Wenhao Zhan(Universitat Autònoma de Barcelona), Cheng Luo(Sun Yat-sen University)
Cited by 1
Related Papers
Diagnosis and prognosis of neutrophil gelatinase-associated lipocalin for acute kidney injury with sepsis: a systematic review and meta-analysis
|Critical Care|2016|144
Human bone marrow mesenchymal stem cells-derived microRNA-205-containing exosomes impede the progression of prostate cancer through suppression of RHPN2
|Journal of Experimental & Clinical Cancer Research|2019|105
Use of Vesical Imaging-Reporting and Data System (VI-RADS) for detecting the muscle invasion of bladder cancer: a diagnostic meta-analysis
|European Radiology|2020|96
Jak/STAT signaling is involved in the inflammatory infiltration of the kidneys in MRL/lpr mice
|Lupus|2010|80
Overexpression of Pim-1 in bladder cancer
|Journal of Experimental & Clinical Cancer Research|2010|79